Early identification of patients at risk for significant left ventricular dilation one year after myocardial infarction. 1995

P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
Department of Cardiology, Erasmus University, Rotterdam, The Netherlands.

We prospectively investigated criteria to identify patients in the early phase of acute myocardial infarction at risk for significant left ventricular (LV) dilation 1 year after myocardial infarction. In 54 patients receiving thrombolysis within 4 hours after onset of symptoms, the end-diastolic volume index (EDVI) and the end-systolic volume index were assessed by two-dimensional echocardiography initially (within 23 +/- 21 hours) and 1 year after myocardial infarction. After 1 year, LV dilation occurred in 51 patients (94%) and was significant (> mean normal value + 2 SDs) in 14 patients (26%). Significant univariate predictors (p < 0.05) for LV dilation were age, anterior myocardial infarction, initial EDVI and end-systolic volume index, enzymatic infarct size, LV end-diastolic pressure, and mitral regurgitation. No other variables obtained from clinical information, two-dimensional echocardiography, or angiography, including residual coronary perfusion or stenosis, had predictive value. The optimal multivariate predictive model was the combination of the initial EDVI and the enzymatic infarct size, which correctly predicted significant LV dilation in 12 of 14 patients and falsely in eight of 39 patients (sensitivity 86%; specificity 79%). Patients at risk for significant LV dilation 1 year after myocardial infarction were identified adequately 3 days after myocardial infarction by the combination of the initial echocardiographic assessment of EDVI and the enzymatic infarct size. Thus a simple method could facilitate the selection of patients for intervention after acute myocardial infarction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations

Related Publications

P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
August 2019, Journal of cardiac failure,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
January 1990, Cardiologia (Rome, Italy),
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
February 1999, The American journal of cardiology,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
May 1998, The American journal of cardiology,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
November 1988, European heart journal,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
January 1991, Cor et vasa,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
October 2005, Kardiologia polska,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
February 1989, Journal of the American College of Cardiology,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
June 1997, Circulation,
P E Assmann, and W R Aengevaeren, and J G Tijssen, and C J Slager, and W Vletter, and J R Roelandt
September 2019, The Journal of nutritional biochemistry,
Copied contents to your clipboard!